Author:
Cojocaru Elena,Mastaleru Alexandra,Tamba Bogdan,Vasile Raluca,Tudor Razvan Cosmin,Ripa Carmen Valerica,Cobzaru Roxana,Leon Maria Magdalena
Reference102 articles.
1. Poredos P, Jezovnik MK. Does the preventive effect of different drugs depend on location of the atherosclerotic process? International Angiology. 2008;27(4):274-280
2. Fuster V. Chronic multivessel disease: Past, present and future. Rev Esp Cardiol. 2008;61(Suppl 2):2-9
3. Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: What is the clinical relevance? Acta Diabetologica. 2009;46(1):1-11. DOI: 10.1007/s00592-008-0057-4
4. Segers D, Weinberg P, Krams R. Atherosclerosis: Cell biology and lipoproteins--shear stress and inflammation in plaque formation: New evidence. Current Opinion in Lipidology. 2008;19(6):627-628. DOI: 10.1097/MOL.0b013e328318db32
5. Moreno PR, Sanz J, Fuster V. Promoting mechanisms of vascular health: Circulating progenitor cells, angiogenesis, and reverse cholesterol transport. Journal of the American College of Cardiology. 2009;53(25):2315-2323. DOI: 10.1016/j.jacc.2009.02.057